Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Palatin to Participate in Canaccord Genuity's 43rd Annual Growth Conference
-
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference
-
AdTheorent to Participate in Upcoming Investor Events
-
Waldencast Announces Participation in the Canaccord Genuity 43rd Annual Growth Conference
-
Media Advisory: Hut 8 to Attend Three Annual Conferences in the Coming Weeks
-
Form 8.3 - [Form-8.3 EMIS GROUP PLC 03 08 2023] - (CGWL)
-
CANACCORD GENUITY GROUP INC. REPORTS FIRST QUARTER FISCAL 2024 RESULTS
-
Vicarious Surgical to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Impinj to Participate in Upcoming Investor Conferences
-
ESS Inc. to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Open Lending to Participate in Upcoming Investor Conferences
-
Spire Global Announces Participation in Upcoming Investor Event
-
Rover to Present at Upcoming Investor Conferences
-
Aurora to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Turnium Technology Group, Inc. Announces Closing of Brokered and Non-Brokered LIFE Offering For Gross Proceeds of C$3 Million
-
ZoomInfo to Participate in Upcoming Investor Conferences
-
Pagaya to Participate in Canaccord Genuity 43rd Annual Growth Conference
-
Nkarta to Participate at Upcoming Investor Conference
-
AdaptHealth Corp. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference
-
Bandwidth to Participate at Upcoming Investor Conferences
-
Iris Energy Announces Monthly Investor Update for July 2023
-
Ameresco to Participate at Upcoming Conference
-
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in August
-
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023
-
Plus Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference
-
Form 8.3 - [BLANCCO TECHNOLOGY GROUP PLC - Opening Declaration - 02 08 2023] - (CGAML)
-
Bridge to Life Divests Certain Assets to TransMedics
-
TransMedics Group (TMDX) Acquires Warm Perfusion EVOSS and Cold Perfusion LifeCradle Technologies from Bridge to Life
-
TransMedics Acquires Warm Perfusion EVOSS™ and Cold Perfusion LifeCradle® Technologies from Bridge to Life
-
Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
Clover Health to Present at Canaccord Genuity 43rd Annual Growth Conference and 2023 Wells Fargo Healthcare Conference
-
Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth Conference
-
Natera to Participate in Canaccord Genuity 43rd Annual Growth Conference
-
Y-mAbs to Participate at Upcoming Investor Conferences
-
Bandwidth Announces Second Quarter 2023 Financial Results
-
Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
-
Trupanion to Participate in the Canaccord Genuity 43rd Annual Growth Conference
-
Alnylam to Webcast Presentation at Canaccord Genuity 43rd Annual Growth Conference
-
Converge Technology Solutions Corp. Announces Participation in the Canaccord Genuity 43rd Annual Growth Conference.
-
Freshworks (FRSH) up 15% on boosted forecast after Q2 beat
-
Faron to Participate in Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
-
Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference
-
Freshworks to Participate in Upcoming Investor Conferences
-
Stoke Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Lavoro to Participate in the Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023
-
Regulus Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Candel Therapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference

